This module allows you to analyze existing cross correlation between DOW and BioShares Biotechnology Clinical Trials. You can compare the effects of market volatilities on DOW and BioShares Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in DOW with a short position of BioShares Biotechnology. See also your portfolio center. Please also check ongoing floating volatility patterns of DOW and BioShares Biotechnology.
|Time Horizon||30 Days Login to change|
Given the investment horizon of 30 days, DOW is expected to generate 2.6 times less return on investment than BioShares Biotechnology. But when comparing it to its historical volatility, DOW is 3.88 times less risky than BioShares Biotechnology. It trades about 0.55 of its potential returns per unit of risk. BioShares Biotechnology Clinical Trials is currently generating about 0.37 of returns per unit of risk over similar time horizon. If you would invest 2,762 in BioShares Biotechnology Clinical Trials on December 21, 2017 and sell it today you would earn a total of 364 from holding BioShares Biotechnology Clinical Trials or generate 13.18% return on investment over 30 days.